Osteoporosis drug fosamax linked to heart problem

Women who have used Fosamax are nearly twice as likely to develop the most common kind of chronically irregular heartbeat (atrial fibrillation) than are those who have never used it, according to research from Group Health and the University of Washington published in the April 28 Archives of Internal Medicine.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news128619838.html">Osteoporosis drug fosamax linked to heart problem</a></p> <p>Women who have used Fosamax are nearly twice as likely to develop the most common kind of chronically irregular heartbeat (atrial fibrillation) than are those who have never used it, according to research from Group Health and the University of Washington published in the April 28 Archives of Internal Medicine.</p>